EWG vs XBI
iShares MSCI Germany ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.49% for EWG.
- • EWG pays a higher dividend yield (1.61%).
Side-by-side metrics
| Metric | EWG | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.49% | 0.35% |
Dividend yield Trailing 12-month yield. | 1.61% | 0.34% |
AUM Assets under management — bigger funds are typically more liquid. | $1.45B | $8.30B |
YTD return | 2.28% | 12.92% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.00 | 1.09 |
P/E ratio | 17.64 | — |
Last price | $42.50 | $133.66 |
Inception | — | — |
Issuer | iShares | State Street |
EWG top holdings
| SIE.DE | Siemens AG | 11.38% |
| SAP.DE | SAP SE | 9.24% |
| ALV.DE | Allianz SE | 8.89% |
| ENR.DE | Siemens Energy AG Ordinary Shares | 8.24% |
| DTE.DE | Deutsche Telekom AG | 6.10% |
| IFX.DE | Infineon Technologies AG | 4.42% |
| MUV2.DE | Munchener Ruckversicherungs-Gesellschaft AG | 3.99% |
| RHM.DE | Rheinmetall AG | 3.74% |
| DB1.DE | Deutsche Boerse AG | 3.03% |
| DBK.DE | Deutsche Bank AG | 2.95% |
XBI top holdings
| APLS | Apellis Pharmaceuticals Inc | 1.87% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.65% |
| TVTX | Travere Therapeutics Inc Ordinary Shares | 1.62% |
| ARWR | Arrowhead Pharmaceuticals Inc | 1.44% |
| TWST | Twist Bioscience Corp | 1.42% |
| SMMT | Summit Therapeutics Inc Ordinary Shares | 1.40% |
| ALKS | Alkermes PLC | 1.38% |
| TGTX | TG Therapeutics Inc | 1.37% |
| MDGL | Madrigal Pharmaceuticals Inc | 1.36% |
| BEAM | Beam Therapeutics Inc | 1.32% |
About EWG
EWG (iShares MSCI Germany ETF) is German large and mid-cap equities. Managed by iShares, the fund carries $1.4B in assets under management, an expense ratio of 0.49%, a dividend yield of 1.61%. Its largest holding is Siemens AG (SIE.DE), which represents 11.4% of the portfolio. Real Estate is the fund's largest sector exposure at 1.3%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $8.3B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.34%. Its largest holding is Apellis Pharmaceuticals Inc (APLS), which represents 1.9% of the portfolio. Financial Services is the fund's largest sector exposure at 0.2%.